Fecal calprotectin below 50 µg/g is widely considered normal, levels between 50 and 250 µg/g fall into an ambiguous middle zone, and anything above 250 µg/g is generally regarded as high. Values above 600 µg/g are strongly associated with inflammatory bowel disease or acute intestinal infections. But those thresholds are far less fixed than they appear on a lab report, and age, medications, and even which brand of test kit your lab uses can shift what “high” actually means for you.
The Standard Cutoffs and What They Mean
Most commercial test kits and clinical guidelines use 50 µg/g as the initial screening threshold. Below that number, the result is treated as normal, and the probability of a serious inflammatory condition in the gut is low. A large review of the evidence found that at the 50 µg/g cutoff, fecal calprotectin has a pooled sensitivity of about 93% and specificity of about 94% for distinguishing inflammatory bowel disease from irritable bowel syndrome in adults.1PubMed Central. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation In plain terms, the test catches most people who have IBD and correctly reassures most people who do not.
Raising the cutoff to 100 µg/g shifts the balance: you become more confident that a positive result truly reflects inflammation (specificity climbs to about 91%), but you start missing a few more cases.2Korean Journal of Clinical Laboratory Science. Age-Related Fecal Calprotectin Concentrations in Healthy Adults Some guidelines recommend that if a result lands between 50 and 100 µg/g, the test should be repeated in about six weeks before anyone decides on further workup.
The international STRIDE-II recommendations, published by the leading IBD research organization, use a different framework geared toward patients who already have IBD. For those patients, a fecal calprotectin below 150 µg/g is the target reflecting remission, and values between 150 and 250 µg/g are described as a “grey zone” where the disease might or might not be quietly active.3PubMed Central (PMC) / BMJ. Calprotectin: from biomarker to biological function These numbers are higher than the 50 µg/g screening cutoff because the clinical question is different: you are no longer asking “does this person have inflammation at all?” but rather “is the inflammation in this known IBD patient controlled well enough?”
What Very High Levels Suggest
Once fecal calprotectin exceeds 250 µg/g, the likelihood of genuine intestinal inflammation rises sharply. In a large pediatric cohort, almost half of children with levels above 250 µg/g were eventually diagnosed with IBD. When levels climbed above 600 µg/g, that proportion reached roughly 60%.4PLOS ONE. Guidance on the interpretation of faecal calprotectin levels in children Values above 600 µg/g are strongly tied to active IBD or acute gut infections.3PubMed Central (PMC) / BMJ. Calprotectin: from biomarker to biological function
In studies comparing ulcerative colitis patients with IBS patients, the gap is dramatic. One study found that ulcerative colitis patients had a mean fecal calprotectin of about 594 µg/g, while IBS patients averaged just 29 µg/g.5PubMed Central. Comparison of Fecal Calprotectin with Different Endoscopic Scores in the Assessment of Ulcerative Colitis Activity and Its Utility in Differentiating IBS from IBD That is roughly a twenty-fold difference. So while no single number can guarantee a diagnosis, extremely high readings are a strong signal that something inflammatory is happening in the gut and that endoscopy is warranted.
It is worth noting that no universally agreed-upon cutoff exists that can diagnose IBD with high accuracy on its own. The test is best understood as a sorting tool: low results make IBD unlikely, and very high results make it probable, but the final answer still comes from looking directly at the intestinal lining with a scope.
Why Your Age Changes Everything
Healthy infants produce fecal calprotectin at levels that would alarm any adult’s gastroenterologist. Babies under three months old have a median level around 375 µg/g, and some perfectly healthy newborns exceed 1,000 µg/g.6PubMed Central. Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months A systematic review of reference values in young children confirms this pattern: the pooled average for infants under one month is about 258 µg/g, dropping to around 116 µg/g between seven and twelve months, and reaching roughly 34 µg/g by age three to four years.7PubMed Central. Establishing reference values for age-related fecal calprotectin in healthy children aged 0–4 years: a systematic review and meta-analysis
The reasons likely involve the developing gut: the immature intestinal barrier and the colonization of the microbiome during the first months of life create a baseline level of immune cell activity that calprotectin reflects. This is normal and does not indicate disease. In a large study of over 11,000 children, the median calprotectin in infants under one year was 51 mg/kg, three to four times higher than in older children. By the teenage years, medians settled into the range of 11 to 19 mg/kg, similar to adults.8PubMed. Concentration of fecal calprotectin in 11,255 children aged 0-18 years
If you are a parent reviewing your infant’s lab results, the standard 50 µg/g threshold does not apply. In the large pediatric cohort mentioned earlier, 47% of all children’s samples exceeded that level.4PLOS ONE. Guidance on the interpretation of faecal calprotectin levels in children A pediatric gastroenterologist will interpret your child’s result in the context of their age rather than against the adult reference range.
Tracking Disease Activity in Known IBD
For people already diagnosed with Crohn’s disease or ulcerative colitis, calprotectin levels serve a different purpose: monitoring how active the disease is and predicting what comes next. Fecal calprotectin correlates directly with the degree of mucosal inflammation seen on endoscopy.9PubMed Central. Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes In ulcerative colitis, the accuracy of calprotectin for predicting active disease on endoscopy is around 90%, while in Crohn’s disease it is somewhat lower, around 80%.10PubMed. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease The gap reflects the nature of the diseases: ulcerative colitis typically inflames the colon in continuous stretches, where calprotectin released from immune cells has an easy path into the stool. Crohn’s can affect patchy or deeper layers of the gut wall, sometimes producing less surface-level calprotectin despite significant inflammation.
Dropping below 250 µg/g on two consecutive measurements is a practical milestone. In one study of ulcerative colitis patients receiving treatment, every patient who achieved two readings below that level showed mucosal healing on follow-up endoscopy, typically within about four months of starting therapy.11PubMed Central. Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis This gives clinicians a way to check whether treatment is working without performing repeated colonoscopies.
Serial measurements are also useful for catching flares before they become obvious. In patients who feel fine clinically, a rising calprotectin level can signal that the gut lining is becoming inflamed again, sometimes weeks before symptoms return.12PubMed Central. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease This gives doctors a head start on adjusting medication. Combined with its role in confirming remission and predicting relapse, calprotectin has become one of the most useful non-invasive tools for managing IBD over time.13PubMed Central. Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
Medications That Can Raise Your Level
An elevated calprotectin result does not always mean inflammatory bowel disease. Two common over-the-counter drug classes can push levels up on their own. An observational study of patients with functional bowel disorders (conditions where the gut misbehaves without structural inflammation) found that those taking proton pump inhibitors had a median calprotectin of 66 µg/g versus 23 µg/g for those not on them. Patients taking NSAIDs like ibuprofen had a median of 57 µg/g compared with 25 µg/g in non-users.14PubMed. Prescription of NSAIDs and proton pump inhibitors are associated with increased faecal calprotectin levels in patients with functional bowel disorder: an observational study
Those differences might not sound large, but they matter when you are sitting right at the diagnostic cutoff. If you take a daily acid blocker or use ibuprofen regularly and your calprotectin comes back at 70 µg/g, your doctor should consider whether the medication alone explains the result before ordering an endoscopy. Ideally, if it is safe to do so, you would stop NSAIDs for a couple of weeks before the stool test to get a cleaner reading.
Calprotectin and Colorectal Cancer
IBD is not the only serious condition that raises fecal calprotectin. Colorectal tumors also provoke an immune response in the gut lining, and the resulting calprotectin elevation can serve as an early warning. A pooled analysis of 23 studies using standard lab methods found an overall sensitivity of 85% for detecting colorectal cancer.15Frontiers in Medicine. Research progress on the diagnostic value of fecal calprotectin in colorectal tumors
An earlier study compared calprotectin with the better-known fecal occult blood test (the one routinely used in cancer screening programs). Among 62 patients with confirmed colorectal cancer, 90% had elevated calprotectin levels, while only 58% had a positive fecal occult blood result. For precancerous adenomatous polyps, calprotectin picked up 55% compared with just 10% for the occult blood test. The trade-off was specificity: calprotectin’s false-positive rate was higher.16PubMed. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma In a separate high-risk population, cancer patients had significantly higher calprotectin levels than all other groups, with a median of about 18 mg/l compared to roughly 7 mg/l in normal subjects.17Gut. Faecal calprotectin levels in a high risk population for colorectal neoplasia
Calprotectin is not currently a standard colorectal cancer screening test; occult blood testing and colonoscopy remain the established approaches. But if your calprotectin comes back high and your doctor is thinking only about IBD, it is worth remembering that tumors and polyps belong on the differential too.
How Much You Can Trust a Single Result
Calprotectin is not perfectly stable even within the same day. In IBD patients, a study measuring variability found that samples taken from different spots within a single bowel movement could differ by 8% to 23%, and samples from different bowel movements on the same day varied by 13% to 26%.18Journal of Clinical Gastroenterology. Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease That level of variation means a single borderline result should be treated cautiously. If your level is 65 µg/g, it could just as easily have read 50 or 80 depending on which part of the stool was sampled and what time of day you collected it.
On top of biological variability, the test itself varies depending on the manufacturer. Different commercial kits use slightly different antibodies and methods, and although most quote similar cutoff values, their actual sensitivity and specificity at a given cutoff differ.19PubMed Central. Faecal Calprotectin One head-to-head comparison of three commonly used kits found overall accuracies for distinguishing IBD from IBS of 97%, 94%, and 84%, respectively.20Intestinal Research. Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease That is a real spread. If you are comparing results over time, ideally the same kit should be used each time, and borderline results near any cutoff deserve a repeat test rather than an immediate clinical decision.
Reducing Unnecessary Endoscopies
One of calprotectin’s most practical benefits is keeping people out of endoscopy suites when they do not need to be there. A diagnostic meta-analysis modeled what happens when you use calprotectin as a pre-screening filter: in a hypothetical group of 100 adults with gut symptoms suspicious enough to consider IBD, routine calprotectin testing could reduce the number who need endoscopy by about 67%. The cost is that roughly two patients with actual IBD might be missed on the first pass and would need a later re-test or endoscopy when symptoms persist.21PubMed. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
That trade-off is generally considered acceptable given that endoscopy is invasive, requires sedation and bowel preparation, and carries its own small risks. For pediatric patients, where avoiding unnecessary procedures carries even more weight, the same analysis estimated a 35% reduction in endoscopies. The smaller reduction reflects the higher prevalence of IBD in children referred for testing, meaning there are fewer “unnecessary” scopes to prevent in the first place.
Calprotectin Beyond the Gut
Calprotectin is a protein released by a type of white blood cell called neutrophils during inflammation, and it shows up wherever those cells congregate. While fecal calprotectin is the version most people encounter, researchers have been measuring calprotectin in blood and saliva for entirely different conditions.
In rheumatoid arthritis, serum (blood) calprotectin levels correlate with disease activity: higher levels track with more swollen joints and greater joint damage on imaging. The same holds for a form of spinal arthritis called axial spondyloarthritis, where calprotectin levels correspond to disease activity scores.22PubMed Central. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis In the joint fluid of rheumatoid arthritis patients, calprotectin concentrations run about ten times higher than in osteoarthritis patients, suggesting the protein may help distinguish between different types of joint inflammation.23Frontiers in Immunology. From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
Salivary calprotectin has a separate niche in oral health. Research has found that people with periodontitis (serious gum disease) have significantly higher salivary calprotectin than those with healthy gums or mild gingivitis.24PubMed Central. Salivary Biomarker Profile in Periodontal Diseases: A Cross-Sectional Study on Leptin, Adiponectin, and Calprotectin One study using a rapid lab method found salivary calprotectin had 91% sensitivity and 73% specificity for detecting periodontitis, making it a potential screening tool for gum disease that might eventually reduce the need for extensive dental probing during routine visits.25PubMed Central. Evaluation of salivary calprotectin as a marker for screening periodontitis using a latex agglutination turbidimetric immunoassay system: a cross-sectional study
These applications remain largely in the research sphere and are not part of routine clinical care for most patients. But they illustrate that calprotectin is not solely a gut marker. If you see the term on a lab panel that has nothing to do with your intestines, these are the contexts where it appears.
Lactoferrin as a Comparable Stool Test
Calprotectin is not the only stool protein used to detect intestinal inflammation. Lactoferrin, another protein released by neutrophils, is sometimes tested alongside it or used as an alternative. In practice, the two tests agree about 90% of the time.26PubMed. Are calprotectin and lactoferrin equivalent screening tests for inflammatory bowel disease? Their diagnostic performance is also similar: one study found overall sensitivity, specificity, and diagnostic efficiency of roughly 78–80% and 83–85% for both markers when assessed together.27PubMed. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
Calprotectin has one practical advantage: it is extremely stable in stool samples at room temperature for up to a week, making it easier to handle without special storage. Lactoferrin degrades more quickly. This stability, combined with a slightly larger evidence base, is why calprotectin has become the default stool inflammation marker in most clinical labs worldwide. If your doctor orders a “stool inflammation test,” it is almost certainly calprotectin.
Acute Infections and Other Non-IBD Causes
A very high calprotectin reading does not automatically mean chronic disease. Acute bacterial gastroenteritis (food poisoning, traveler’s diarrhea) can produce calprotectin levels well above 600 µg/g that fall back to normal once the infection clears. If you had a stool test during an acute bout of diarrhea with fever, the result may reflect the infection rather than an underlying condition.
Other causes of elevated calprotectin include celiac disease, microscopic colitis, diverticulitis, and the use of certain medications already discussed. Even heavy alcohol consumption and vigorous exercise have been reported to transiently raise levels. For any borderline or moderately elevated result, the clinical picture matters as much as the number itself. A calprotectin of 120 µg/g in someone with chronic loose stools and weight loss carries a very different meaning than the same number in someone who just recovered from a stomach bug and takes daily ibuprofen.
This is why gastroenterologists tend to interpret calprotectin results in ranges rather than treat a single cutoff as gospel. Below 50 µg/g is reassuring. Between 50 and 250 µg/g demands context and often a repeat test. Above 250 µg/g justifies endoscopy in most situations. And above 600 µg/g, the question shifts from “is there inflammation?” to “what is causing this inflammation?” The number is a compass heading, not a destination.